How Much Kratom Is Too Much in a Day? The Published Numbers, and Why We Will Not Print a Ceiling

There is no number. Not one we are withholding; one that does not exist in the peer reviewed literature. What exists is a handful of surveys that asked people what they take, what felt like too much and what happened when they stopped, plus one study that watched ten regular users take a morning dose in a clinic. This page puts those figures in a table with their sample sizes, converts them into milligrams of mitragynine where the paper allows it, holds our own product up against them, and explains why the honest answer to the question in the title is a margin rather than a ceiling.

Why "grams a day" is the wrong unit, and what the right one is

Every answer to this question you will find online is written in grams of leaf, and grams of leaf is a unit that does not tell you what you took. Mayo Clinic, in its June 2024 consumer page on kratom, puts it in one sentence: "the amount of the active part in kratom leaves can vary greatly. So it's hard to know the effects of a given dose." The variation is not small. When the Tampa Bay Times had twenty products tested at the University of Florida in 2023, a small liquid shot "contained 114 milligrams of mitragynine and 24 milligrams of speciociliatine. Neither amount was listed on the bottle." A bottle of one extract "contained 367 milligrams of mitragynine", which the paper worked out was "equivalent to over 70 capsules" of a popular capsule brand. The strongest powder per gram came in a bag "containing more than 2,600 milligrams of mitragynine". And of the twenty products: "Five had no information about ingredients. Eleven had no dosing instructions. Thirteen had no details about potency."

So the same "three grams" could be a mild leaf or something several times stronger, and the person taking it would have no way to know. The unit that lets you compare a product to anything in the literature is milligrams of mitragynine per serving, which is the number on a certificate of analysis. Ours are on our lab results page. If the product you use does not come with that number, everything below is harder to apply to it, and that is a fact about the product rather than about the research.

What people take: every figure with its sample size

The best dose survey in the literature is Smith and colleagues, published in Frontiers in Pharmacology in March 2022, and it is worth knowing how small it is before you read the numbers. It surveyed 129 adults with lifetime kratom use recruited through an online crowdsourcing platform; 104 of them had ever used kratom regularly. People reported their dose in whatever unit they used, so the gram figures come from the 37 to 45 people who measured in grams. Here is what they said, with the n for each cell.

Two older figures that the same paper cites belong to other authors and should be attributed to them. Garcia-Romeu and colleagues, in 2020, "found the typical dose range was <1 g (8.6%) to >7 g (8.9%), with most respondents reporting that they consumed 1 to 3 g (49.0%) or 4 to 6 g (33.4%) per consumption." And Grundmann, in 2017, reported that "most beneficial effects were observed in doses of 1 to 3 and 3 to 5 g if taken 2 to 3 times per day; in contrast, most adverse effects required higher doses of >8 g and higher frequency of dosing between 4 to 5 times per day of daily use." The Frontiers paper adds a conversion worth keeping: "most capsules appear to contain about 0.5 g", so the capsule column above is roughly half the gram column, which is what you see.

Notice what is not in that table. There is no toxic dose, no maximum daily dose and no safe dose. Every row is a description of what a few dozen people said about their own use. The Frontiers authors say so themselves: "There is no peer-reviewed research about safe or effective dosing of kratom".

The margin is the actual finding

Read the last two gram rows against each other. The dose people described as effective without unwanted effects averaged 6.85 g. The dose they described as a bit too much averaged 8.68 g. The paper's discussion draws the conclusion that matters: "the average difference between effective kratom doses and doses that were perceived as 'too much' (and unwanted) is not large, meaning that people using kratom, particularly those unfamiliar with kratom, may inadvertently dose too much." And in its conclusions: "The margin between effective doses and doses that were perceived as 'too much' appears narrow enough to warrant careful attention to kratom doses, irrespective of a given dosing unit."

Under two grams of leaf, on average, between working and unwanted. Now put that next to the potency spread from the section above, where one bag of powder carried more than 2,600 mg of mitragynine and one shot carried 114 mg with nothing on the label. A margin that narrow, measured in a unit that varies that much, is why "how much is too much" has no gram answer. The people who wrote the best study on the subject did not give one, and they had the data in front of them.

Ten people, one morning, under observation

The only published study we could find that measured a real dose in a real body, rather than asking about it, is Smith and colleagues again, in the Journal of Addiction Medicine in January 2024. Ten adults who used kratom at least three times a week came to a clinic and took their usual morning dose while staff measured them for a little over three hours. They had used kratom for 6.6 years on average. "Mean session dose was 5.16 grams (median=4.38; range=1.1-10.9) leaf powder." Seven of the ten used kratom seven days a week, and "Typical doses/day ranged from 1-5".

What makes this study different is that the products were assayed, so the dose is reported in mitragynine per kilogram of body weight, not grams of leaf. The mean was 0.77 mg/kg, the median 0.594, and the range 0.190 to 1.698 mg/kg. For a 70 kg adult that works out at roughly 54 mg of mitragynine on average, 42 mg at the median, and a range of about 13 mg to 119 mg. That conversion is our arithmetic, not the paper's; the paper reports per kilogram, and your weight is not 70 kg unless it is.

What happened after the dose was, on the whole, not much. "Relative to baseline, physiological changes were minor." Pupils got smaller and stayed smaller for more than 160 minutes. On the question "Do you feel high?" the mean score was 15.2 out of 100 at 40 minutes; on "Do you feel intoxicated?" it was 4.8. "No AEs were reported by participants or observed by staff." Product alkaloid content was in the expected range, "with no elevated concentrations to suggest (for example) 'spiking'". And the authors are clear about what they cannot tell you: "our findings cannot speak to long-term AEs from chronic use", the sample "was not powered to detect" dose response effects, and "participants were under direct observation for only four hours". One participant planned to stop after the study, "feeling that the benefits were not proportionate to perceived unknowns (e.g., risk of liver injury) or side effects (e.g., tolerance, decreased libido)."

Where the record connects amount to harm, and where it does not

People want the dose question answered because they assume a line exists on the other side of which harm begins. Here is what the published record connects to amount, stated at the strength the evidence supports and no stronger.

Effects on stopping. In the Frontiers survey, more weeks of regular use predicted worse unwanted effects when kratom was not used for a day or more (p = 0.02). The amount consumed per week "closely approached, but did not fully achieve, significance", at p = 0.07. The authors' own summary: "persons who use kratom at higher doses regularly may expect greater odds of feeling unwanted or adverse effects when use is paused." An indication, in their word, not a threshold.

Use disorder. Hill and colleagues, surveying 2,061 current consumers in 2023, found that 25.5 percent met adapted criteria for kratom use disorder, most of them mild or moderate, and that the characteristics associated with it "were related to being male, young, consuming kratom frequently, and having psychiatric and substance use disorder comorbidities." Frequency, note, rather than a gram figure. The paper reports no dose.

Concentrated products. This is the part that applies to us. Nebraska Medicine, in September 2025, quotes its addiction psychiatrist Sara Zachman: "Kratom, however, can be addictive, especially at high doses or with concentrated products." The same article, in its own voice, describes what its clinicians are seeing: "Many users report escalating doses. Some consume over 10 kratom shots a day, leading to withdrawal symptoms like cravings, mood changes, runny nose, muscle aches and insomnia." Ten shots at the 114 mg the Times measured in one brand would be over a gram of mitragynine in a day. That is a multiplication we did, not a case the article reports, and it is the reason the per serving number matters more than any gram figure on this page.

The liver. The NIDA page, dated March 2026, says "Case reports do show regular, long-term, kratom use in large amounts may be associated with serious liver problems. These cases appear to occur unpredictably in a small minority of people who use kratom". Large amounts, long term, unpredictably. No figure. The same page states that "studies have not yet established that these effects depend on the amount or method of kratom consumed".

Death. The Tampa Bay Times built a database of Florida autopsy reports and counted 587 kratom related accidental overdoses through June 2022, 46 of which, by the paper's own definition, listed kratom or mitragynine as the only substance on the cause of death. That is one state and a newspaper's count, not a government figure. Two of its findings speak to amount. "Among kratom-only overdoses, about half involved people who had what experts described as alarming levels of mitragynine in their system: concentrations higher than 1,000 nanograms per milliliter of blood." And: "At least a fifth of those who overdosed solely on kratom used products manufactured to be more concentrated than traditional, fresh leaf forms of the herb." Against both, the paper's own caution: "Scientists haven't yet agreed on a fatal dosage for kratom." The paper reports that a University of Florida researcher, Abhisheak Sharma, believes the small vials "can contain several times more mitragynine than he thinks is safe to consume over an entire day", and it gives no number for that day. Nobody has.

Our own tablet against those numbers

We could stop there and let you draw the conclusion about extracts yourself. Using our own certificate costs us something and using a competitor's would cost us nothing, so here is ours. PRIME Extract Tablets, lot 02122026, report issued 20 February 2026: mitragynine 26.0 percent by weight, which at a measured unit weight of 0.713 grams is 186 mg of mitragynine per tablet. That is the figure our tolerance article was built around, and it is on the lab results page with every other certificate we hold.

Hold that against the clinic study. The largest single morning dose observed in ten regular users, converted at 70 kg, was about 119 mg of mitragynine. The mean was about 54 mg. One of our tablets is 186 mg. One tablet of our own product carries more mitragynine than the biggest dose in the only observational study of typical doses we could find, and more than three times its average. That is not a boast, and we would ask you not to read it as one; it is the reason the tolerance article told you to multiply, and the reason this article exists.

The comparison has limits, and we would rather name them than have them named for us. Ten people is ten people. They took leaf powder, not a tablet, and absorption may differ. The 70 kg figure is a convention. The study measured a single dose and says nothing about a day. None of those limits moves the direction of the arithmetic. If the question is "how much kratom is too much in a day" and your unit is one of our tablets, then one tablet is already above every dose in the published observational record, and two a day is 372 mg, which is not a quantity any study has watched anyone take.

Why we will not print a ceiling

Our commercial interest argues for a generous number, printed confidently. A seller's number reads as a license: anything under it feels approved, and the seller wrote it. We refused in the tolerance article and we refuse here, for three reasons that are all quotations. Mayo: "Experts don't know what level of kratom can cause those problems. People can overdose with kratom, but it's rare." Frontiers: "There is no peer-reviewed research about safe or effective dosing of kratom". NIDA: "studies have not yet established that these effects depend on the amount or method of kratom consumed". Three institutions with no reason to agree with each other, agreeing that the number does not exist. A seller who prints one has invented it.

What we will say, because the evidence says it, is that the margin is narrow and the unit is unreliable, and that a concentrated product moves you along that margin faster than a leaf product does. Our earlier piece on mitragynine toxicity covers what the literature says about the compound itself at high exposure. This one is about the daily amount, and its answer is that the daily amount has no published ceiling, only a published slope.

What to do with the numbers instead

Find the milligrams of mitragynine per unit on the certificate for what you take. Multiply by the number of units in a day. That figure is your daily exposure, and it is the only number on this page that belongs to you. Now put it next to the observed single dose range from the clinic study, roughly 13 to 119 mg at 70 kg, and next to the survey's under two gram margin between working and unwanted, and notice which side of both you are on. Then do it again in three months. A daily exposure that climbs while the effect stays flat is the working definition of tolerance, and it is the earliest thing you can observe about your own use without a laboratory or anyone's permission.

Three things the surveys treat as signals, which you can check for yourself: needing more for the same effect; feeling unwell on a day you skip; taking more, or more often, than you meant to. If two of those are true, the useful next step is a clinician, and the number on the certificate is the most useful thing you can bring to that appointment, because it turns "a few tablets" into a quantity a prescriber can reason about. Poison Control, 1-800-222-1222, answers questions about a specific product at any hour. If you think a figure on this page is wrong, tell us; it gets corrected with the next review date on it.

Nobody in this category is going to give you the ceiling you searched for, and the ones who do are guessing. What you can have instead is your own number, the published range it sits against, and a clear view of which direction it has been moving. On this subject that is not a consolation prize. It is the whole of what the evidence supports.

Disclaimer: this page summarizes publicly available material as of 21 September 2026 and links to primary sources so you can check them. Milligram conversions marked as our arithmetic are ours, not the cited papers'. It is general information, not medical advice, and no substitute for a clinician. Survey figures come from small, self-selected samples and are not population estimates. Statements about botanical products have not been evaluated by the Food and Drug Administration, and no product is intended to diagnose, treat, cure or prevent any disease.